Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000441
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Drug Therapy for Alcohol Detoxification
Sponsor:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Organization:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Study Overview
Official Title:
Carbamazepine and Lorazepam in Outpatient Detoxification
Status:
COMPLETED
Status Verified Date:
2002-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project will provide relevant clinical information for primary care practitioners treating alcohol withdrawal syndrome in outpatient settings This double-blind placebo- controlled clinical trial will compare the effectiveness of lorazepam Ativan and carbamazepine Tegretol in alcoholics who meet the criteria for a diagnosis of uncomplicated alcohol withdrawal syndrome Participants are randomized to five days of treatment with a 1-week posttreatment followup
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: